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Three-Dimensional-Engineered Matrix to Study Cancer
Stem Cells and Tumorsphere Formation:
Effect of Matrix Modulus
Xiaoming Yang, PhD,1,2,* Samaneh K. Sarvestani, BS,1,* Seyedsina Moeinzadeh, BS,1
Xuezhong He, PhD,1 and Esmaiel Jabbari, PhD1
Maintenance of cancer stem cells (CSCs) is regulated by the tumor microenvironment. Synthetic hydrogels
provide the flexibility to design three-dimensional (3D) matrices to isolate and study individual factors in the
tumor microenvironment. The objective of this work was to investigate the effect of matrix modulus on tu-
morsphere formation by breast cancer cells and maintenance of CSCs in an inert microenvironment without the
interference of other factors. In that regard, 4T1 mouse breast cancer cells were encapsulated in inert polyeth-
ylene glycol diacrylate hydrogels and the effect of matrix modulus on tumorsphere formation and expression of
CSC markers was investigated. The gel modulus had a strong effect on tumorsphere formation and the effect
was bimodal. Tumorsphere formation and expression of CSC markers peaked after 8 days of culture. At day 8,
as the matrix modulus was increased from 2.5 kPa to 5.3, 26.1, and 47.1 kPa, the average tumorsphere size
changed from 37 – 6 mm to 57 – 6, 20 – 4, and 12 – 2 mm, respectively; cell number density in the gel changed from
0.8 – 0.1 · 105 cells/mL to 1.7 – 0.2 · 105, 0.4 – 0.1 · 105, and 0.2 – 0.1 · 105 cells/mL after initial encapsulation of
0.14 · 105 cells/mL; and the expression of CD44 breast CSC marker changed from 17 – 4-fold to 38 – 9-, 3 – 1-, and
2 – 1-fold increase compared with the initial level. Similar results were obtained with MCF7 human breast
carcinoma cells. Mouse 4T1 and human MCF7 cells encapsulated in the gel with 5.3 kPa modulus formed the
largest tumorspheres and highest density of tumorspheres, and had highest expression of breast CSC markers
CD44 and ABCG2. The inert polyethylene glycol hydrogel can be used as a model-engineered 3D matrix to
study the role of individual factors in the tumor microenvironment on tumorigenesis and maintenance of CSCs
without the interference of other factors.
Introduction
Breast cancer is the most common cancer among wo-men in industrialized countries. The development of
breast cancer is a multiple-step process and regulated by the
tumor microenvironment.1 This process may take many
years and is difficult to follow in vivo. Therefore, there is a
need to develop in vitro models to study the molecular basis
of tumorigenesis and progression. Most in vitro studies use
standard two-dimensional (2D) cell culture. However, cells
grown on 2D tissue culture behave differently from those
grown in physiological 3D environment due to the lack of
proper cell–cell and cell–matrix interactions as well as the
gradient of nutrients and growth factors, which are known to
play critical roles in cancer initiation, progression, and me-
tastasis.2 For example, when cancer cells are cultured in 2D
plates, their malignancy is reduced compared with those
under in vivo conditions.3 Animal models are also frequently
used to study molecular pathways and drug response in
cancer research. In these cases, either animal tumors grown
in syngeneic animals or human tumors grown in immuno-
compromised animals are used. Therefore, animal models
may not adequately reproduce the features of human cancers
in vivo.
To bridge the gap between the 2D cell culture system and
the in vivo system, the 3D in vitro cell culture system has
emerged as another approach for cancer research. In many 3D
models, cell lines or cells from dissociated tissues are embedded
in 3D matrices and cultured to promote cell–cell interaction,
adhesion, migration, and in vivo–like morphogenesis. Com-
parison between 2D and 3D cultures has revealed significant
differences in all aspects of cell behavior, that is, from cell shape
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and growth to gene expression and response to stimuli.4 Var-
ious types of materials have been used to generate a 3D matrix.
Type 1 collagen and Matrigel are the most widely used
matrices5 because they are biocompatible and support adhesion
and growth of many cell types.6,7
Alginate and agarose gels are also used as a matrix to
study the behavior of breast cancer cells under a 3D condi-
tion.8,9 However, it is difficult to isolate and study cell re-
sponse to individual factors in the microenvironment with
naturally derived matrices that have many interactions with
cell surface receptors.10
In that regard, synthetic gels provide enormous flexibility
in designing 3D matrices with a wide range of mechanical,
physical, and biological properties that are crucial to the
maintenance, differentiation, maturation, and fate of the
encapsulated cells.11–13 Among them, polyethylene glycol
(PEG) hydrogel, due to its inert nature, has been used ex-
tensively as an engineered matrix for cell encapsulation to
elucidate the effect of factors in the microenvironment on cell
fate.14–17 Among the factors in the microenvironment, matrix
stiffness or elastic modulus plays an important role in reg-
ulating cell function in 2D as well as 3D culture systems.18 In
3D culture systems, elastic modulus of the matrix can direct
differentiation of encapsulated stem cells and shift the bal-
ance of cell proliferation and apoptosis.19–21 In vivo, cells
have the ability to sense and respond to matrix stiffness by
synthesizing the appropriate extracellular matrix (ECM)
composition as the mechanical properties and composition of
hard and soft tissues differ significantly. Cells need to re-
spond appropriately to the environmental cues for surviv-
al.22 Likewise, the proliferation, differentiation, migration,
and apoptosis of cancerous cells in the tumor tissue are
regulated by matrix stiffness.23–25
Although the effect of matrix stiffness on the response of
normal stem cells has been studied extensively,26–29 the effect
on cancer stem cells (CSCs) encapsulated within an inert mi-
croenvironment has not been investigated. Normal stem cells
and CSCs use similar signaling pathways to maintain their
stemness. However, they may respond to the environmental
cue differently. The microenvironment or niche under normal
conditions inhibits stem cell proliferation and differentiation.
However, CSCs, due to mutations in the cell, are self-sufficient
with respect to proliferation.30,31 It has been proposed that the
stem cell niche is converted from proliferation inhibitory to
signals favoring cell proliferation in the case of CSCs.32
The objective of this work was to investigate the effect of
matrix elastic modulus on the formation, growth, and
maintenance of CSCs by tumor cells encapsulated in PEG
hydrogels, in the absence of attached ligands that interact
with cell surface receptors. We show that the formation and
maintenance of 4T1 mouse breast cancer cells and MCF7
human breast cancer cells are modulated by the elastic
modulus of the PEG matrix. This inert engineered 3D matrix
provides a novel tool to control and investigate the effect of
microenvironmental factors on maintenance of CSCs in vitro.
Materials and Methods
Materials
PEG (nominal molecular weight 4.6 kDa), dichloromethane
(DCM), N,N-dimethylformamide, diethyl ether, and hexane
were purchased from Acros (Fairfield, OH). Calcium hydride,
triethylamine (TEA), paraformaldehyde, 4,6-diamidino-2-
phenylindole (DAPI), insulin, penicillin, and streptomycin were
purchased from Sigma-Aldrich (St. Louis, MO). Basic fibroblast
growth factor (bFGF) and epidermal growth factor (EGF) were
purchased from Lonza (Allendale, NJ). Bovine serum albumin
(BSA) was obtained from Jackson ImmunoResearch (West
Grove, PA). Dulbecco’s phosphate-buffered saline (PBS), trypsin–
ethylenediaminetetraacetic acid, RPMI-160 cell culture me-
dium, Dulbecco’s modified Eagle’s medium (DMEM)–F12
medium, fetal bovine serum (FBS), Alexa Fluor 594 Phalloi-
din, and Quant-it PicoGreen double-stranded DNA (dsDNA)
reagent kit were purchased from Invitrogen (Carlsbad, CA).
Horse serum was purchased from PAA Laboratories
(Etobicoke, Ontario) and DMEM-F12 was from Mediatech
(Manassas, VA). Spectro/Por dialysis tube (molecular weight
cutoff 3.5 kDa) was purchased from Spectrum Laboratories
(Rancho Dominquez, CA). DCM was purified by distilla-
tion over calcium hydride. All other solvents were reagent
grade and were used as received without further purifica-
tion. Anti-CD44 antibody (HCAM, DF1485) was from Santa
Cruz Biotechnology (Santa Cruz, CA). Monoclonal anti-
bromodeoxyuridine (anti-BrdU) antibody proliferation mar-
ker (produced in mouse) was obtained from Sigma-Aldrich.
Fluorescent conjugated secondary antibodies were obtained
from Invitrogen. 4T1 mouse breast carcinoma and MCF7
human breast adenocarcinoma cell lines were received from
the Scripps Research Institute (La Jolla, CA) and American
Type Culture Collection (Manassas, VA), respectively. The
live/dead calcein AM (cAM) and ethidium homodimer-1
(EthD) cell viability/cytotoxicity kit was purchased from
Molecular Probes (Life Technologies, Grand Island, NY).
Macromer synthesis and characterization
The PEG macromer was functionalized with acrylate
groups to produce polyethylene glycol diacrylate (PEGDA)
by the reaction of acryloyl chloride with hydroxyl end
groups of PEG, as shown in Figure 1A. TEA was used as the
reaction catalyst. Prior to the reaction, PEG was dried by
azeotropic distillation from toluene to remove residual
moisture. The polymer was dissolved in dried DCM in a
reaction flask; the flask was immersed in an ice bath to cool
the polymer solution and limit the temperature rise from the
exothermic reaction. In a typical reaction, 5.6 mL acryloyl
chloride and 9.7 mL TEA, each dissolved in DCM, were ad-
ded drop-wise to the reaction with stirring. The reaction was
allowed to proceed for 12 h under nitrogen flow. After com-
pletion of the reaction, the solvent was removed by rotary
evaporation and the residue was dissolved in anhydrous
ethyl acetate to precipitate the by-product triethylamine hy-
drochloride salt. Next, ethyl acetate was removed by vacuum
distillation; the macromer was re-dissolved in DCM and
precipitated twice in ice-cold ethyl ether. The macromer was
dissolved in dimethylsulfoxide and dialyzed against distilled
deionized water to remove the by-products. The PEGDA
product was freeze-dried and stored at - 20C. The chemical
structure of the functionalized macromer was characterized
by a Varian Mercury-300 proton nuclear magnetic resonance
(1H-NMR) (Varian, Palo Alto, CA) at ambient conditions with
a resolution of 0.17 Hz. The sample was dissolved in deuter-
ated chloroform at a concentration of 5 mg/mL and 1% v/v
tetramethylsilane (TMS) was used as the internal standard.
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Hydrogel synthesis and measurement of gel modulus
The PEGDA macromers were crosslinked in aqueous
solution by ultraviolet (UV)-initiated radical polymerization
with 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl) ke-
tone (Irgacure 2959; CIBA, Tarrytown, NY) photoinitiator.
Five milligrams of initiator was dissolved in 1 mL PBS at
50C. The macromer was dissolved in PBS by vortexing and
heating to 50C. To prepare 7.5%, 10%, 15%, 20%, and 25%
PEGDA hydrogel precursor solutions, 22.5, 30, 45, 60, and
75 mg of PEGDA macromer were mixed with 278, 270, 255,
240, and 225mL of the initiator solution, respectively, by
vortexing for 5 min. For cell loading, 1.4 · 105/mL 4T1 cells
suspended in PBS were added to the macromer solution and
mixed gently with a glass rod. The hydrogel precursor so-
lutions were degassed and transferred to a polytetra-
fluoroethylene (PTFE) mold (5 cm · 3 cm · 750 mm), covered
with a transparent glass plate, fastened with clips, and UV
irradiated with a BLAK-RAY 100 W mercury, long-wave-
length (365 nm) UV lamp (Model B100-AP; UVP, Upland,
CA) for 10 min. Disk-shaped samples were cut from the gel
using an 8-mm cork borer and swollen in PBS for 24 h at
37C. To measure the gel’s elastic modulus, samples were
loaded on the Peltier plate of the rheometer (TA Instruments,
New Castle, DE) and subjected to a uniaxial compressive
force at a displacement rate of 7.5 mm/s. The slope of the
linear fit to the stress–strain curve for 5%–10% strain was
taken as the elastic modulus (E) of the gels.
CSC culture and characterization
4T1 and MCF7 tumor cells were cultured in RPMI-1640
medium with 10% FBS under 5% CO2 at 37C. Cells were
trypsinized after reaching 70% confluency. PEGDA macro-
mer was dissolved in PBS and sterilized by filtration with a
0.2 mm filter. Next, 1.4 · 105/mL 4T1 or MCF7 cells sus-
pended in PBS were added to the macromer solution with
final PEGDA concentrations ranging 5–25 wt%, and mixed
gently with a pre-sterilized glass rod. The cell-suspended
hydrogel precursor solution was crosslinked with UV for
10 min. After crosslinking, the gel was cut into disks and
incubated in stem cell culture medium in ultra-low-attachment
tissue culture plates under 5% CO2. The stem cell medium
consisted of DMEM-F12 supplemented with 0.4% BSA, 5mg/
mL insulin, 40 ng/mL bFGF, 20 ng/mL EGF, 5% horse se-
rum, 100 U/mL penicillin, and 100mg/mL streptomycin.33
For growing tumorspheres in suspension, trypsinized 4T1
cells were cultured on ultra-low-attachment tissue culture
plates with stem cell culture medium under 5% CO2 at 37C
as described previously.33–35 The gold standard for charac-
terization of CSC tumorspheres for stemness is by the ability
to form tumor in vivo.36,37 To test for tumor formation, a
stable 4T1 cell line that expressed luciferase (4T1-Luc) was
established as described.38 Luciferase expression vector
pGL4.50[Luc2/CMV/Hygro] (Promega, Madison, WI) was
transfected into 4T1 cells by Lipofectamine 2000 (Invitrogen),
according to the manufacturer’s instructions, to generate a cell
line expressing luciferase as a reporter.38 After 24 h, cells
were trypsinized and cultured in RPMI-1640 medium with
400mg/mL of hygromycin for 3 weeks to generate 4T1-Luc
cells. 4T1-Luc cells were cultured on adhesion plates with
regular RPMI-1640 culture medium or on ultra-low-attachment
plates with stem cell culture medium as described previously.
After one week, cells were trypsinized and counted. Different
number of cells (5000 and 50,000 cells from adhesion plates or
500, 1000, and 5000 tumorsphere cells from ultra-low-
attachment plates) was injected subcutaneously in syngeneic
Balb/c mice (6 mice/group). One week after inoculation,
100mL of D-Luciferin (30 mg/mL; Caliper, Hopkinton, MA)
was injected subcutaneously and mice were imaged 10 min
after Luciferin injection by Caliper’s IVIS Spectrum imaging
system (Caliper Life Sciences, Hopkinton, MA).
Cell imaging and determination of cell number
To determine cell viability, gels were stained with cAM/
EthD live/dead dyes 2 days after encapsulation to image live
and dead cells, respectively. Stained samples were imaged
with an inverted fluorescent microscope (Nikon Eclipse Ti-e;
Nikon, Melville, NY). Cell viability was quantified by di-
viding the image into smaller squares and counting the
FIG. 1. (A) Reaction scheme for
acrylation of PEG macromer and
(B) 1H-NMR spectrum of PEGDA
macromer. The chemical shifts
between 5.85 and 6.55 ppm due to
acrylate hydrogens are enlarged in
the inset of the NMR spectrum.
PEG, polyethylene glycol; PEGDA,
polyethylene glycol diacrylate;
NMR, nuclear magnetic resonance.
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number of live and dead cells. At each time point, the gel
samples were removed from the culture media and stained for
imaging. Samples were rinsed twice with PBS and fixed with
4% paraformaldehyde for 3 h. After fixation, cells were per-
meabilized using PBS containing 0.1% Triton X-100 for 5 min.
After rinsing, cells were incubated with Alexa 488 phalloidin
(1:200 dilution) and DAPI (1:5000 dilution) to stain actin fil-
aments of the cell cytoskeleton and cell nuclei, respectively.
Stained samples were imaged with a Nikon Eclipse Ti-e
inverted fluorescent microscope. For visualization of cell
uniformity, a confocal fluorescent microscope (Zeiss LSM-510
META Axiovert; Carl Zeiss, Germany) was used to obtain 2D
images (90-mm-thick layers) of the stained gels in the direction
of thickness, as described.39 For determination of cell number,
the gel samples were homogenized, cells were lysed, and
aliquots were used to measure the dsDNA content using a
Quant-it PicoGreen assay as described.40 Briefly, an aliquot
(100mL) of the working solution was added to 100mL of the
cell lysate and incubated for 4 min at ambient conditions. The
fluorescence of the solution was measured with a plate reader
(Synergy HT; Bio-Tek, Winooski, VT) at emission and exci-
tation wavelengths of 485 and 528 nm, respectively. Measured
fluorescent intensities were correlated to cell numbers using a
calibration curve constructed with 4T1 or MCF7 cells of
known concentration ranging from zero to 105 cells/mL.
BrdU retention assay and immunofluorescent imaging
BrdU label retention was used to identify mammary CSCs
as described.41,42 Nonconfluent 4T1 cells were incubated with
10 mM of BrdU for 10 days to label the DNA by incorporating
BrdU into replicating DNA in place of thymidine. Next, the
BrdU-labeled cells were encapsulated in the gel and incubated
in stem cell culture medium to form tumorspheres as de-
scribed previously. At each time point, the retention of BrdU
in the encapsulated cells was imaged by immunofluorescent
staining with anti-BrdU antibodies as described.41 At each
time point, tumorspheres encapsulated in the gel samples
were processed and stained for immunofluorescent imaging
of BrdU-labeled cells or CD44 marker as described.43 Gel
samples were fixed and permeabilized for 3 h at 4C in PBS
containing 4% paraformaldehyde and 1% Triton X-100, fol-
lowed by rinsing with PBS (3 · 10 min). Tumor spheroids
were then dehydrated in an ascending series of methanol at
4C in PBS (25%, 50%, 75%, and 95% for 30 min each and 100%
for 5 h) and rehydrated in the same descending series and
washed in PBS (3 · 10 min). Next, samples were blocked with
PBS containing 0.1% Triton X-100 (PBST) and 3% BSA over-
night at 4C and washed with PBS (2 · 15 min). Then, samples
were incubated with primary antibodies (anti-CD44 antibody
or anti-BrdU antibody) diluted in PBST on a gently rocking
rotator at 4C overnight followed by rinsing with PBST
(4 · 30 min). Samples were then incubated with Alexa Fluor–
conjugated secondary antibodies for 2 h and rinsed with PBST
(4 · 10 min). The cell nuclei were counterstained with DAPI
(1:5000 dilution in PBS) and imaged with a Nikon Eclipse Ti-e
inverted fluorescent microscope.
mRNA analysis
Total cellular RNA of the gel samples was isolated using
TRIzol (Invitrogen) as described.40 About 250 ng of the ex-
tracted purified RNA was reverse transcribed to cDNA by
SuperScript II Reverse Transcriptase (Invitrogen) with the
random primers. The obtained cDNA was subjected to real-
time quantitative polymerase chain reaction (RT-qPCR) am-
plification with appropriate gene-specific primers. RT-qPCR
was performed to analyze the differential expression of CSC
markers CD44 (4T1 and MCF7), CD24 (4T1), ABCG2 (4T1
and MCF7), and SCA1 (4T1) genes with SYBR green
RealMasterMix (Eppendorf, Hamburg, Germany) using Bio-
Rad iCycler PCR system (Bio-Rad, Hercules, CA). The ex-
pression level of GAPDH gene was used as an internal con-
trol. The primers for RT-PCR were designed by Primer 3
software (http://frodo.wi.mit.edu). The following forward
and reverse primers synthesized by Integrated DNA Tech-
nologies (Coralville, IA) were used: mouse GAPDH: forward
5¢-CAT GGC CTT CCG TGT TCC TA-3¢ and reverse 5¢-CCT
GCT TCA CCA CCT TCT TGA-3¢; mouse CD44: forward 5¢-
GAA TGT AAC CTG CCG CTA CG-3¢ and reverse 5¢-GGA
GGT GTT GGA CGT GAC-3¢; mouse CD24: forward 5¢-CTT
CTG GCA CTG CTC CTA CC-3¢ and reverse 5¢-GAG AGA
GAG CCA GGA GAC CA-3¢; mouse ABCG2: forward 5¢-AGC
AGC AAG GAA AGA TCC AA-3¢ and reverse 5¢-GGA ATA
CCG AGG CTG ATG AA-3¢; mouse SCA1: forward 5¢-TGG
ACA CTT CTC ACA CTA-3¢ and reverse 5¢-CAG AGC AAG
AGG GTC TGC AGG AG-3¢; human GAPDH: forward 5¢-
GAG TCA ACG GAT TTG GTC GT-3¢ and reverse 5¢-TTG
ATT TTG GAG GGA TCT CG-3¢; human CD44: forward 5¢-
GGC TTT CAA TAG CAC CTT GC-3¢ and reverse 5¢-ACA
CCC CTG TGT TGT TTG CT-3¢; and human ABCG2: forward
5¢-CAC CTT ATT GGC CTC AGG AA-3¢ and reverse 5¢-CCT
GCT TGG AAG GCT CTA TG-3¢. The relative gene expres-
sion levels were quantified by the 2–DDCT method as de-
scribed.44,45 The relative gene expression was expressed as
fold difference compared with that at time zero.
Statistical analysis
Data are expressed as mean – standard deviation. All ex-
periments were done in triplicate. Significant differences
between groups were evaluated using a two-way analysis of
variance (ANOVA) with replication test followed by a two-
tailed Student’s t-test. A value of p < 0.05 was considered
statistically significant.
Results
Macromer characterization and hydrogel modulus
The reaction scheme for acrylation of PEG macromer and
the NMR spectrum of PEGDA are shown in Figure 1A and
1B, respectively. The chemical shifts with peak positions at
3.6 and 4.3 ppm were attributed to the methylene hydrogens
( = CH2) of PEG attached to ether ( - CH2 - O - CH2 - ) and
ester ( - CH2 - OOC - ) groups, respectively. The shifts with
peak positions from 5.85 to 6.55 ppm (see inset in Fig. 1B)
were attributed to the vinyl hydrogens ( - CH = CH2) of the
acrylate group at the end of each macromer arm as follows:
peak positions in the 5.82–5.87 ppm range were associated
with the trans proton of unsubstituted carbon of the Ac;
those in the 6.10–6.20 ppm range corresponded to the pro-
tons bonded to monosubstituted carbon of the Ac; and those
in the 6.40–6.46 ppm range were associated with the proton
of unsubstituted carbon of the acrylate group. The number of
acrylate groups per macromer was determined from the ratio
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of NMR shifts between 5.85 and 6.55 ppm (acrylate hydro-
gens) to those at 3.6 and 4.2 ppm (PEG hydrogens).46,47 Based
on NMR results, the average degree of acrylation was 89%
and there was on average 1.8 – 0.1 acrylates in the PEGDA
macromer. Disk-shaped hydrogels with 8-mm diameter and
750-mm thickness were fabricated for determination of elastic
modulus and cell encapsulation. The effect of macromer
concentration and incubation time on the elastic modulus of
PEGDA hydrogel, loaded with 4T1 cells, is shown in Figure 2.
Macromer concentration in the precursor solution affected
the elastic modulus of the hydrogel. The elastic modulus
increased from 2.5 – 0.7 kPa to 5.3 – 1.4, 26.1 – 6.9, 47.5 – 11.6,
and 68.6 – 9.3 kPa as the macromer concentration was in-
creased from 5% to 10%, 15%, 20%, and 25%, respectively.
The elastic modulus of the gels, with encapsulated 4T1 cells,
did not change significantly during 14 days of incubation in
the cell culture medium, as shown in Figure 2.
Tumorsphere characterization
Tumorsphere formation on ultra-low-attachment plates is
a commonly used method to enrich CSCs in vitro, while the
gold standard for characterization of CSC tumorspheres is by
the ability to form tumor in vivo.36,37 4T1-Luc cells were
cultured on regular adhesion plates or ultra-low-attachment
plates. After one week, cells in monolayers (adhesion plates)
and in spheres (ultra-low-attachment plates) were collected
and subcutaneously inoculated in syngeneic Balb/c mice.
Tumor formation in mice was determined by imaging the
expression of luciferase one week after inoculation. Figure 3
compares tumor formation by cells on adhesion plates (Fig.
3A) and cells from tumorspheres on ultra-low-attachment
plates (Fig. 3B). The left and right images in Figure 3A are
for 5000 and 50,000 4T1-Luc cells on adhesion plates. The
left, center, and right images in Figure 3B are for 500, 1000,
and 5000 4T1-Luc cells from tumorspheres on ultra-low-
FIG. 2. Effect of macromer concentration on elastic modu-
lus of 4T1-cell-loaded (1.4 · 105 cells/mL) PEGDA hydrogels
with incubation time. Error bars correspond to mean – 1 SD
for n = 3. Color images available online at www.liebertpub
.com/tea
FIG. 3. Comparing in vivo tumor formation of 4T1 cells from adhesion plates (A) with 4T1 cells from tumorspheres on ultra-
low-attachment plates (B). The left and right images in (A) show tumor formation by inoculation of 5000 and 50,000 4T1-Luc
cells, respectively. The left, center, and right images in (B) show tumor formation by inoculation of 500, 1000, and 5000 4T1-
Luc cells from tumorspheres. 4T1-Luc cells were inoculated subcutaneously in Balb/c mice. After one week, the expression of
luciferase in tumors was imaged. The light blue, dark blue, and red color images correspond to low, medium, and high
luciferase intensity, proportional to the size of the tumor formed. Color images available online at www.liebertpub.com/tea
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attachment plates. According to the images in Figure 3, 1000
tumorsphere cells were sufficient to form a tumor in vivo
while it required 50,000 regular tumor cells to form a tumor.
These results demonstrate that tumorspheres formed by 4T1
cells in vitro had enriched CSC subpopulation.
Tumorsphere formation in hydrogel
4T1 tumor cells were encapsulated in PEGDA hydrogels
with elastic moduli ranging from 2 to 70 kPa and cultured in
stem cell medium for 2 weeks. Images of live and dead cells 2
days after encapsulation in PEGDA gels with moduli of 2.5,
5.3, 26.1, and 47.5 kPa are shown in Figure 4A through 4D,
respectively. Based on image analysis, the percent viable cells
for 2.5, 5.3, 26.1, 47.5, and 68.6 kPa gels were 94 – 4, 91 – 3,
92 – 3, 90 – 4, and 89 – 4, respectively. These results show that
the gel modulus did not have a significant effect on viability
of 4T1 cells after encapsulation. To determine cell uniformity
and viability, a confocal microscope was used to image cells
in the direction of thickness and the results are shown in
Figure 4E1–E8. Images in Figure 4E show uniform cell seeding
and cell viability within the gel in the thickness direction.
Fluorescent images in Figure 5 show the extent of cell
aggregation and spheroid formation with incubation time for
4T1 gels with modulus of 2.5 kPa (Fig. 5, column 1), 5.3 kPa
(Fig. 5, column 2), 47.5 kPa (Fig. 5, column 3), and MCF7 gel
with 5.3 kPa (Fig. 5, column 4). Rows 1, 2, 3, and 4 in Figure 5
correspond to incubation times of 5, 8, 11, and 14 days, re-
spectively. Spheroid formation was observed in soft gels
with moduli of 2.5 and 5.3 kPa as early as day 5 (columns 1,
2, and 4 in Fig. 5) while cells in the more stiff gels with
modulus of 47.5 kPa and higher remained as single cells or
small cell aggregates ( < 25mm). MCF7 human breast cancer
cells also formed spheres when encapsulated in the gel with
modulus of 5.3 kPa (Fig. 5, column 4). At any time point, size
of the tumorspheres in the 5.3 kPa gel was higher than that of
2.5 kPa gel. Lower magnification images showing the num-
ber density of 4T1 (Fig. 6, column 1) and MCF7 (Fig. 6, col-
umn 2) tumorspheres in PEGDA gels with elastic moduli of
2.5 kPa (Fig. 6, row 1), 5.3 kPa (Fig. 6, row 2), 26.1 kPa (Fig. 6,
row 3), and 47.5 kPa (Fig. 6, row 4) after 8 days of incubation
are shown in Figure 6, respectively. According to Figure 6,
the tumorsphere size and number density initially increased
with increasing matrix modulus from 2.5 to 5.3 kPa and then
decreased when modulus was increased to 26.1 and 47.5 kPa.
Tumorspheres with diameter > 100mm were observed only
in the gels with modulus of 2.5 and 5.3 kPa but the fraction of
large tumorspheres (> 100 mm) was significantly higher in the
5.3 kPa gel. It should be noted that the size of MCF7 spher-
oids in the gels was less than that of 4T1.
Tumorsphere size and number density
The effect of hydrogel modulus on average tumorsphere
diameter and size distribution with incubation time is shown
in Figure 7A and 7B for 4T1 cells and Figure 7D and 7E for
MCF7 cells, respectively. The average 4T1 tumorsphere di-
ameter increased from 10 mm at day zero to 80, 140, 30, 15,
and 10 mm after 14 days as the gel modulus increased from
2.5 kPa to 5.3, 26.1, 47.5, and 68.6 kPa, respectively, while
tumorsphere diameter for MCF7 cells increased from 8mm at
day zero to 60, 90, 29, 13, and 11 mm after 14 days. For 4T1
cells in the softest gel (2.5 kPa modulus), 25% of the cell ag-
gregates at day 8 had < 20mm size (single-cell fraction) while
there was no single-cell subpopulation in the gel with 5.3 kPa
modulus. For MCF7 cells after 8 days, 28% and 3% of the cell
FIG. 4. Live (green) and dead (red) image of 4T1 cells 2 days after encapsulation in PEGDA hydrogels with moduli of (A)
2.5 kPa, (B) 5.3 kPa, (C) 26.1 kPa, and (D) 47.5 kPa. The scale bar in images (A–D) is 200mm. Based on image analysis, the percent
viable cells for 2.5, 5.3, 26.1, 47.5, and 68.6 kPa gels was 94 – 4, 91 – 3, 92 – 3, 90 – 4, and 89 – 4, respectively. Images (E1–E8) on the
right show the uniformity of cell seeding and cell viability in successive 90mm layers in the direction of thickness for 5.3 kPa gel,
obtained with a confocal fluorescent microscope. The scale bar in images (E1–E8) is 200mm. Color images available online at
www.liebertpub.com/tea
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aggregates had < 20 mm size in 2.5 and 5.3 kPa gels, respec-
tively. Further, for the gel with 5.3 kPa modulus, 23% and 8%
of 4T1 tumorspheres and 8% and 3% of MCF7 tumorspheres
had size in the range of 80–120 and 120–200 mm, respectively.
The fraction of tumorspheres with 0–20-mm diameter (single-
cell fraction) increased with increasing gel modulus for 4T1
and MCF7 cells and all of the cells in the highest modulus gel
(68.6 kPa) remained as single cells.
The number density of viable 4T1 and MCF7 cells in
PEGDA gels with different moduli is shown in Figure 7C
and 7F, respectively. The cell count increased with time for
all groups but the gels with moduli of 2.5 and 5.3 kPa had the
highest cell count at all time points. At each time point, the
change in cell count with gel modulus was bimodal; that is,
the cell count initially increased for moduli of 2.5 and 5.3 kPa
and then decreased for gels with moduli > 26 kPa. At day 14,
the 5.3 kPa gel had 3-fold higher 4T1 cells and 1.3-fold higher
MCF7 cells than the 2.5 kPa gel; the 5.3 kPa gel had 10-fold
higher 4T1 and MCF7 cells than those gels with > 26 kPa
modulus. In general, the gel modulus has similar effects on
4T1 and MCF7 cells. These results demonstrated that the gel
with modulus of 5.3 kPa had the highest potential for tu-
morsphere formation in the absence of ligand–receptor in-
teractions.
Tumorsphere marker expression
One of the unique properties of CSCs is asymmetrical
division and retention of DNA labeling.37 Based on this
feature, BrdU retention is a commonly used method to
characterize CSCs. 4T1 cells were labeled with BrdU before
encapsulation in the PEGDA gel with 5.3 kPa modulus and
the intensity of BrdU staining was compared with those cells
cultured on ultra-low-attachment plates. Figure 8 compares
BrdU staining of 4T1 cells in suspension culture on ultra-low-
attachment plates (Fig. 8A, C) with those encapsulated in
PEGDA hydrogels (Fig. 8B, D). Images A and B in Figure 8
are after 8 days of culture while images C and D are after 14
days. After 8 and 14 days, cells encapsulated in the gel dis-
played higher level of BrdU retention than those in suspen-
sion cultures, suggesting that the encapsulated tumorspheres
had higher fraction of CSCs.
FIG. 5. Evolution of tumorsphere formation by 4T1 tumor cells encapsulated in PEGDA hydrogels with elastic modulus of
2.5 kPa (left column), 5.3 kPa (center left column), and 47.5 kPa (center right column), and MCF7 tumor cells encapsulated in
the 5.3 kPa gel (left column) as a function of incubation time. Rows 1, 2, 3, and 4 correspond to incubation times of 5, 8, 11,
and 14 days, respectively. At each time point, encapsulated cells were stained with phalloidin for cytoskeleton (red) and
DAPI for nucleus (blue), and imaged with an inverted fluorescent microscope. DAPI, 4,6-diamidino-2-phenylindole. Color
images available online at www.liebertpub.com/tea
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The expression of breast CSC markers for tumorspheres
grown in PEGDA gels with different moduli is shown in
Figure 9. Figure 9A–D shows the expression of CD44, CD24,
ABCG2, and SCA1 for 4T1 cells and Figure 9E and 9F shows
the expression of CD44 and ABCG2 for MCF7 cells. ABCG2
of ABC transporter proteins is responsible for CSC drug re-
sistance and SCA1 (stem cell antigen-1) is a cell surface
protein known to be associated with breast CSCs.48–50 CD44
and ABCG2 are well-studied markers in both mouse and
human breast CSCs.51,52 Although CD24 - is also a marker
often used as a breast CSC marker, recent studies indicate
that both CD44 + /CD24 - and CD44 + /CD24 + cells display
CSC phenotypes in MCF7 cells.53 SCA1 is a murine stem cell
marker and it is unclear whether SCA1 is a CSC marker in
human cancer cells. In addition, the coding sequence of hu-
man SCA1 is not well defined. Therefore, only the expression
of CD44 and ABCG2 markers was examined for MCF7 cells.
4T1 cells in the gel with elastic modulus of 5.3 kPa had the
highest CD44 expression and lowest CD24 expression for all
time points. CD44 expression of 4T1 and MCF7 cells initially
increased and reached a maximum at day 8 for 2.5 and
5.3 kPa gels and at day 11 for 26.1 kPa gel. CD44 expression
then decreased with incubation time. 4T1 and MCF7 cells
encapsulated in the gels with moduli of 47.5 and 68.6 kPa did
not show an increase in CD44 expression in 14 days. This
biphasic marker expression with time was also observed for
ABCG2 marker in 4T1 and MCF7 cells. At day 8, CD44 and
ABCG2 expression of 4T1 cells increased by 2.2- and 1.8-fold,
FIG. 6. Representative images of
tumorsphere density for 4T1 (left
column) and MCF7 (right column)
cells encapsulated in PEGDA
hydrogels with elastic modulus of
(A) 2.5 kPa (first row), 5.3 kPa
(second row), 26.1 kPa (third row),
and 47.5 kPa (fourth row) after 8
days of incubation. At each time
point, encapsulated cells were
stained with phalloidin for
cytoskeleton (red) and DAPI for
nucleus (blue), and imaged with an
inverted fluorescent microscope.
Color images available online at
www.liebertpub.com/tea
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respectively, with increase in gel modulus from 2.5 to 5.3
kPa; those for MCF7 cells increased by 1.2- and 1.7-fold with
increase in gel modulus from 2.5 to 5.3 kPa.
To determine whether tumorspheres in the hydrogel had a
higher level of stem cell population than those formed on
ultra-low-attachment plates, CD44 immunostaining of the
4T1 cells encapsulated in PEGDA gels (5.3 kPa modulus) was
compared with those cultured on ultra-low-attachment
plates after 5, 8, and 11 days of culture, and the results are
shown in Figure 10. Tumorspheres grown in the gel and on
ultra-low-attachment plate both had high level of CD44
staining after 5 and 8 days of culture and the intensity of
CD44 staining started to decrease after 8 days of culture for
both groups. This was consistent with our CD44 mRNA data
(see Fig. 9). However, tumorspheres grown in the gel had a
more intensive CD44 staining than those on ultra-low-
attachment plates for longer incubation times of 11 and 14
days, suggesting that the 3D microenvironment and gel
stiffness modulated the maintenance of stemness in CSCs.
Discussion
The ECM stiffness regulates proliferation and differentia-
tion of many cell types.54–56 Development of solid tumors is
often accompanied by an increase in the stiffness of the local
environment. For example, high tissue density is a known
risk factor for developing invasive breast carcinoma.57,58 The
stiffness of normal human breast tissue is lower than 4 kPa
while that of cancerous breast tissue can be up to 40 kPa.59
Analysis of several cell lines in collagen matrices has re-
vealed that matrix stiffness can dramatically affect the
growth of certain cell lines but has little effect on others.60 For
example, the growth of MDA-MB-231 cells, a highly malig-
nant human breast cancer cell line, is significantly enhanced
FIG. 7. Average tumorsphere size (A, D), tumorsphere size distribution (B, E), and cell count (C, F) for 4T1 and MCF7
tumor cells encapsulated in PEGDA hydrogels with different elastic moduli and incubated for up to 14 days. Graphs (A–C)
and (D–F) correspond to 4T1 and MCF7 cells, respectively. The symbol asterisk indicates statistically significant difference
between the test group and all other groups at the same time point (A, C, D, and F) or at the same tumorsphere diameter
range (B, E). Error bars correspond to mean – 1 SD for n = 3. Color images available online at www.liebertpub.com/tea
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with increasing matrix stiffness while the growth of MCF-
10a, a nonmalignant breast epithelial cell line, is relatively
insensitive to matrix stiffness within a certain range.60 These
results suggest that the response of cancer cells to matrix
stiffness is not only dependent on the cancer but also on
malignancy of the cancer. Further, it has been reported that
nontumorigenic breast epithelial cells loose cell polarity and
increase proliferation when cultured in matrices with 4.5 kPa
stiffness.61 In addition, normal murine mammary gland or
well-differentiated mammary epithelial cells cultured in
high-density collagen matrices display an invasive pheno-
type.62 Mechanistic studies suggest that these mechanically
induced transformations are associated with enhanced focal
adhesion kinase (FAK) followed by FAK-dependent ERK
and Rho activity.62,63 These pathways have been suggested
as the circuit linking matrix stiffness to cytoskeleton.62,63
PEGDA hydrogels used in this study do not have cell ad-
hesion ligands that are believed to mediate mechanosen-
sing.26 The cell response to stiffness in the inert PEG matrix
may be through the ECM secreted by the encapsulated tu-
mor cells. For example, human mesenchymal stem cells
(hMSCs) encapsulated in PEG hydrogels, in the absence of
adhesive ligands, secret their own ECM through which dif-
ferentiation is directed by mechanotransduction.64
According to rubber elasticity theory, the gel elastic
modulus is proportional to the density of elastically active
chains or crosslink density.65 The network crosslink density
increased with increasing acrylate concentration in PEGDA
precursor solution, leading to the increase in matrix modu-
lus. The range of elastic moduli selected in this study was
based on the reported stiffness of breast tumor tissue.59,66
Increasing evidence suggests that CSCs are responsible for
tumor initiation and metastasis as well as drug resistance.67
Maintenance of CSCs in vivo is highly dependent on the tu-
mor microenvironment. Stem cell microenvironments in vivo
are polarized structures with individual stem cells exposed
to different niche components.68,69 We have shown in this
study that the formation of spheroids by 4T1 tumor cells
encapsulated in an inert matrix is biphasic with respect to
matrix modulus in the 2.5–68.6 kPa range. The initial increase
in tumorsphere size and cell number density with elastic
modulus may be attributed to a deviation from normal tissue
stiffness (*0.17 kPa), leading to matrix reorganization and
change in the number and lifetime of integrin-mediated in-
teractions and related pathways.26 It has been reported that
the sphere size of breast cancer cells encapsulated in collagen
gels increased with elastic modulus from 0.17 to 1.20 kPa.61
In another study, it was shown that the proliferation and
sphere size of hepatocellular carcinoma cells encapsulated in
PEG–collagen gels increased with decreasing elastic modulus
from 4 kPa (corresponding to the modulus of healthy liver) to
0.7 kPa.70 A decrease in sphere size and cell number for gel
moduli > 5.3 kPa can be attributed to a decrease in mesh size
and increase in retractive force of the gel network, leading to
a negative contribution on the cell proliferation and sphere
formation.71 The average pore size or the mesh size of the
hydrogel can affect diffusion of nutrients and oxygen and
tumor cell motility. For example, HepG2 hepatocellular
carcinoma cells form larger spheres when encapsulated in
alginate gels with larger pore sizes.72 The mesh size of the
PEGDA gels was calculated from the modulus and equi-
librium swelling ratio of the gels using the Peppas and
Barr-Howell equation, as described.73 As the macromer
concentration was increased from 7.5% to 10%, 15%, 20%,
and 25%, the mesh size decreased significantly from 93 –
4 nm to 67 – 3, 53 – 3, 34 – 2, and 25 – 2 nm, respectively.
Therefore, the bimodal effect of gel modulus on tumorsphere
formation may be due to the changes in the network mesh
size, as well as the gel modulus, that can affect cell–matrix
interactions and nutrient diffusion.
The formation of tumorspheres is associated with breast
CSC markers, suggesting that sphere formation in the gel
matrix is not caused by simple cell aggregation but by CSCs.
It has been shown that matrix stiffness can alter the expres-
sion of CSC markers in hepatocellular carcinoma cells en-
capsulated in a collagen matrix.23 Unlike collagen and other
FIG. 8. BrdU staining of 4T1
tumorspheres formed in suspension
culture on low-adhesion plates (A,
C) and formed by encapsulation in
PEGDA hydrogels (B, D). Images
(A) and (B) are after 8 days of
incubation while images (C) and
(D) are after 14 days. Prior to
tumorsphere formation, 4T1 cells
were incubated with BrdU for 10
days to achieve stable labeling. The
presence of BrdU in the cells was
confirmed by immunofluorescent
staining (green). The cell nuclei
were stained with DAPI (blue).
BrdU, bromodeoxyuridine. Color
images available online at
www.liebertpub.com/tea
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biological gels, varying PEGDA macromer concentration
only changes the gel stiffness, not the ligand density in the
matrix. Our results suggest that the stiffness of the tumor
tissue alone is sufficient to affect the fate of tumor cells. A
biphasic behavior of CSC marker expression with time may
be attributed to the fraction of CSCs in the gel. The CSC
fraction initially increased with loss of normal tumor cells in
the inert low-adhesive PEGDA gel. Then, the fraction started
to decrease as the rate of differentiation of CSCs to normal
cancer cells was higher than the rate of transformation of
differentiated cells to CSCs.74 The highest expression of
CD44 and ABCG2 markers at day 8 and largest tumorsphere
size for 4T1 and MCF7 cells encapsulated in the gel with
5.3 kPa modulus indicates the existence of highest fraction of
stem-like subpopulation at this matrix modulus. The fraction
of CSCs in a tumor also depends on the microenvironment.67
The concentration of oxygen and nutrients in the center of
large tumorspheres may be lower than that for small spheres,
leading to the formation of a hypoxic condition in the central
part of the spheres in the 5.3 kPa gel, which in turn can in-
crease the expression of CSC markers.67,75
Naturally derived gels, such as alginate and agarose gels,
have also been used to study the behavior of breast cancer
cells under a 3D condition. For example, highly invasive rat
mammary carcinoma MTLn3-Mena cells form tumorspheres
when encapsulated into alginate hydrogels, and the
FIG. 9. Effect of gel elastic
modulus on the relative
mRNA expression levels of
CD44 (A), CD24 (B), ABCG2
(C), and SCA1 (D) markers of
4T1 cells, and CD44 (E) and
ABCG2 (F) markers of MCF7
cells encapsulated in PEGDA
hydrogels with incubation
time. The mRNA expression
levels of the markers for 4T1/
MCF7 cells before
encapsulation were used as
reference (set equal to one).
The symbol asterisk indicates
statistically significant
difference between the test
group and all other groups at
the same time point. Error
bars correspond to mean – 1
SD for n = 3. Color images
available online at
www.liebertpub.com/tea
EFFECT OF MATRIX MODULUS ON TUMORSPHERE FORMATION 679
formation of tumorsphere can be inhibited by coculture with
embryonic stem cells.8 In another study, encapsulation of
neoplastic cells in a growth-restricting hydrogel composed of
agarose matrix leads to the selection of a stem cell subpop-
ulation and the formation of tumorspheres.9 However, our
work demonstrates for the first time that CSCs can be
maintained in the inert microenvironment of synthetic PEG
hydrogels and the elastic modulus of the gel affects the
growth of tumorspheres. The growth and maintenance of
CSCs in other synthetic gels, such as polyhydroxyethyl
methacrylate, polyvinylpolypyrrolidone, and polyvinyl al-
cohol, is of interest and will be investigated in future works.
Our results also show that 4T1 cells form higher number of
tumorspheres when encapsulated in the PEG hydrogel
compared with suspension cultures on low-adhesion plates.
There are two possible explanations for this observation. One
explanation is that the 3D hydrogel culture system more
closely mimics the in vivo tissue environment than the sus-
pension cultures with respect to the survival of CSCs. Evi-
dence supporting this notion is that cancer cells have fewer
number of CSCs in 2D cultures than the in vivo.76 The elastic
retractive force of the gel network can promote viability and
proliferation of CSCs by enhancing FGF signaling and pro-
tein Kinase B (AKT) activation.77,78 The other explanation is
that the retractive force of the gel can induce the transfor-
mation of differentiated bulk cancer cells into CSCs. The
transformation between CSCs and differentiated cancer cells
is not unidirectional. Recent studies indicate that inducing
FIG. 10. Expression pattern of
CD44 marker of 4T1 tumorspheres
formed in suspension culture on
low-adhesion plates (column A)
and formed by encapsulation in
PEGDA hydrogel with 5.3 kPa
elastic modulus (column B). Images
in rows 1, 2, 3, and 4 are after 5, 8,
11, and 14 days of incubation,
respectively. The cell nuclei were
stained with DAPI (blue). Color
images available online at
www.liebertpub.com/tea
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epithelial-to-mesenchymal transition (EMT) is sufficient to
transform a differentiated cancer cell into a CSC.79,80 In the
process of EMT, tumor cells undergo cytoskeletal reorgani-
zation with subsequent changes in cell adhesion. At the
molecular level, the key features of EMT include the altered
expression of cell membrane proteins, such as E-cadherin
and b-catenin, and cell polarity. It is known that mechanical
properties as well as biochemical composition in the tumor
microenvironment play profound roles in EMT.81,82 It is
possible that the hydrogel stiffness shifts the balance of EMT
by regulating the conformation of cell membrane receptors
and cell polarity. One example of such mechanism is epi-
dermal growth factor receptor (EGFR) signaling that has been
associated with breast CSC maintenance.83 Compression of the
cell membrane by the gel retractive force can shrink the in-
terstitial space and increase the local ligand and receptor
concentrations, thus increasing the autocrine EGFR signaling.84
Several signal transduction pathways, such as Notch, Wnt,
and Hedgehog, have been identified to be critical for CSC
maintenance.85 It is unclear how these pathways are regu-
lated by the matrix modulus as these pathways are normally
activated by ligand binding to cell surface receptors, which
was absent in PEGDA gels. A possible explanation is re-
ceptor clustering induced by compression of the cell by the
elastic retractive force of the gel network. Future work
should focus on the effect of gel modulus, in the absence of
ligand–receptor interaction, on the expression and activity
of the components of these pathways and how stiffness-
modulated tumorsphere formation is altered when these
pathways are blocked. It should be mentioned that the effect
of matrix modulus on viability, growth, and differentiation
of normal stem cells has been investigated. For example, the
fate of MSCs encapsulated in alginate or agarose gels con-
jugated with cell-binding RGD peptides is regulated by the
elastics modulus of the matrix. The encapsulated MSCs dif-
ferentiated to the osteogenic lineage in the gel with an in-
termediate modulus (11–30 kPa) while they differentiated
into the adipogenic lineage in the gel with a low modulus
(2.5–5 kPa).26 Similarly, MSCs encapsulated in PEG–silica
gels with an intermediate elastic modulus (10–30 kPa) dis-
play edosteogenic phenotype.86 It appears that matrix
modulus affects the differentiation of normal stem cells while
it affects maintenance and growth of tumorspheres in the
case of CSCs.
In this work, the effect of matrix modulus on tumorsphere
formation and maintenance of CSCs was investigated in an
inert matrix without the interference of other factors. The
PEG matrix can be used as a 3D model system to dissect the
role of individual factors in the tumor microenvironment on
tumorigenesis and maintenance of CSCs. For example, dif-
ferent types and concentration of ligands that interact with
tumor cells can be conjugated to the PEGDA matrix without
altering the physical and mechanical properties of the gel to
study the effect of ligand–receptor interactions on CSC
maintenance.
Conclusions
4T1 breast cancer cells were encapsulated in inert PEGDA
hydrogels and the effect of gel modulus on tumorsphere
formation and the expression of markers for CSCs were in-
vestigated. The gel modulus had a strong bimodal effect on
tumorsphere formation and the expression of CSC markers.
The gel elastic modulus ranged from 2.5 to 70 kPa. 4T1 cells
encapsulated in the gel with modulus of 5.3 kPa had the
highest growth rate and formed the largest and highest
number of tumorspheres. Similar results were obtained
when MCF7 human adenocarcinoma cell line was encapsu-
lated in the PEGDA hydrogel. Tumorspheres formed by
mouse 4T1 and human MCF7 cells encapsulated in the
5.3 kPa gel showed the highest expression of breast CSC
markers CD44 and ABCG2 and the expression of CSC
markers peaked after 8 days of incubation. For the first time
in this work, the effect of matrix modulus on tumorsphere
formation and maintenance of CSCs was investigated in an
inert matrix without the interference of other factors. The
inert PEG matrix can be used as a 3D model system to dissect
the role of individual factors in the tumor microenvironment
on tumorigenesis and maintenance of CSCs.
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